Reuters • 5 hours ago
Italian healthcare group Bracco is working on a potential bid for the radiology supplies unit that Germany's Bayer AG is considering selling, people close to the matter said. Bracco has mandated an investment bank to find a partner for a possible joint offer for the unit, which may be valued at more than 4 billion euros (4.3 billion), they said. Bayer has not yet made a final decision on whether it will sell, but earlier this year mandated Goldman Sachs as a sellside advisor and sent out information to prospective buyers, the people said, adding that the auction had been expected to start next year.
American City Business Journals • 9 hours ago
Bayer AG plans to acquire a product portfolio from St. Joseph-based animal health company Boehringer Ingelheim Vetmedica Inc., the two companies jointly announced Wednesday. Once the deal is completed, Bayer would acquire BIVI's Cydectin portfolio, an anti-parasitic treatment approved for use in cattle and sheep. The deal is a further step toward Boehringer Ingelheim acquiring Merial, the animal health subsidiary of Sanofi (SNY), as part of a $25.5 billion asset swap.
Market Realist • 9 hours ago
The founder and president of Greenlight Capital, David Einhorn, discussed his investment ideas at the Robin Hood Investors Conference.
Financial Times • 8 days ago
When Werner Baumann and Hugh Grant unveiled their $66bn agreement for Germany's Bayer to acquire US seeds maker Monsanto, the respective chief executives hailed the transaction as nothing short of a combination ...
American City Business Journals • 9 days ago
Bayer AG CEO Werner Baumann walked into his office in Leverkusen, Germany, at 6:15 a.m. and settled into the day by reading the morning news. It was Nov. 9, and Germany — which is six hours ahead of Washington, D.C. — was waking up to the results of the U.S. presidential election. Republican Donald Trump’s victory occurred less than a month after Bayer and Monsanto Co. (MON) agreed to a $66 billion merger.
Reuters • 14 days ago
Canada may ban an insect-killing chemical used to protect crops because it harms aquatic bugs, including midges and mayflies, while the government continues to investigate whether imidacloprid poses a risk to bees. Imidacloprid, made by Bayer AG, should be phased out within five years, the Pest Management Regulatory Agency (PMRA) said on Wednesday. Imidacloprid is part of a class of pesticides called neonicotinoids, also called neonics, that are applied as a seed treatment or sprayed on plants' leaves.
Moody's • 15 days ago
London, 23 November 2016-- While fresh clouds are gathering on the horizon with Brexit, uncertainty over trade agreements with the US under a future Trump administration and higher pension deficit liabilities, ...
Investopedia • 15 days ago
The companies say that the VitalFields team will join Climate's operations, which marks Climate's first step into the European market.
American City Business Journals • 16 days ago
Gov. Jay Nixon said his trip to Germany to meet with Bayer AG, the company poised to acquire Monsanto Co. (MON), was successful and that Bayer executives have reaffirmed their commitment to keep St. Louis as the North American headquarters of the newly merged company, according to a release. Monsanto and “its employees are a critical pillar in St. Louis’ international leadership in the plant science economy, agriculture research and education, and outstanding contributors to cultural institutions and charitable organizations,” Nixon said in a statement after his Nov. 18 trip to Germany-based Bayer.
Investopedia • 17 days ago
Trump's pick of Senator Jeff Sessions for the role of Attorney General suggest that the heavy regulatory scrutiny could soon lighten up.
BAYRY : Summary for BAYER AG SPON ADR REP 1 NPV - Yahoo Finance
Bayer AG (BAYRY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||96.63 - 97.64|
|52 Week Range||91.53 - 128.90|
|PE Ratio (TTM)||16.25|
|Dividend & Yield||2.87 (3.08%)|
|1y Target Est||116.00|